Concepedia

Paras Mehta

PM

10

Publications

699

Citations

10

H-Index

2019

Active since

Affiliations

Massachusetts General Hospital(Current)

University of Utah

Erasmus MC

Janssen (United States)

Genomics (United Kingdom)

Paras Mehta is an author at Massachusetts General Hospital specializing in drug resistance, antimicrobial pharmacokinetics, and epidemiology.

ORCID

Top concepts

Publications per year

2019–2022

10

Publications

10

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Jennifer C. E. Lane, James Weaver, Kristin Kostka et al. · The Lancet Rheumatology · 2020 · 151 citations · Full text

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study

Jennifer C. E. Lane, James Weaver, Kristin Kostka et al. · 2020 · 132 citations · Full text

, , +25

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

Edward Burn, Seng Chan You, Anthony G. Sena et al. · Nature Communications · 2020 · 107 citations · Full text

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Albert Prats‐Uribe, Anthony G. Sena, Lana Yin Hui Lai et al. · BMJ · 2021 · 70 citations · Full text

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

Briana R. Halle, Allison Betof Warner, Farzana Y. Zaman et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Rows per page

1–5 of 10